When is it time to turn the tide? View online
The Coalition for Hemophilia B is a non-profit organization that does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, services, opinions, healthcare providers or other information that may be contained in or available through this email or linked web site.
Changing Hemophilia® logo.
 
When is it time to turn the tide?
Managing hemophilia isn’t always easy, but with Changing Hemophilia®, staying up-to-date on hemophilia research can be.
 Find out more 
Let’s stay in touch. Sign up for e-mail updates from Changing Hemophilia®.
  New research is exploring hemophilia management strategies that aim to target different parts of the coagulation cascade, provide different administration options, and more.
If you’re struggling to manage your hemophilia, you should know that you’re not alone.
According to a 2022 survey, people with hemophilia reported that they continue to experience emotional and physical burdens. How do the results of the survey compare with your experience?
 Explore the data 
More to explore
Did you know that different approaches to hemophilia management are being researched?
Learn more about what’s next
 
Join our community
Sign up for the Changing Hemophilia® e-mail list to learn about educational resources, community events, and what’s new in hemophilia management.
 
Let’s connect on social media!
There’s a whole community of people who understand your experience. The Changing Hemophilia® Facebook and Instagram are great places to find them.
Learn tips to manage a bleeding disorder   Find out about events   Connect with others who get it
Find Us on Facebook
 
Connect on Instagram
Please do not respond to this email. If you would like to contact us, please click here or call 1‑877‑744‑2579.
Changing Hemophilia® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2023 Novo Nordisk  All rights reserved.  US22HRBD00225  April 2023
Novo Nordisk logo.
Novo Nordisk logo.